Cervical Dystonia Global Clinical Trials Review, H1, 2017

2017-05-31
Price :
Published : May-2017
No. of Pages : 71

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cervical Dystonia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cervical Dystonia to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Cervical Dystonia Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Cervical Dystonia 30
Jun 05, 2017: Revance Reports Additional Positive Week 24 Efficacy Results from RT002 Injectable Phase 2 Cervical Dystonia Trial 30
May 18, 2017: Revance Announces Positive Top-Line 24-Week Duration of Effect Results in All Three Cohorts in RT002 Injectable Phase 2 Cervical Dystonia Trial 30
Clinical Trial Profile Snapshots 32
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Source 71

List of Tables

Cervical Dystonia Therapeutics, Global, Clinical Trials by Region, 2017* 7
Cervical Dystonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Cervical Dystonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Cervical Dystonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Cervical Dystonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Cervical Dystonia Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Cervical Dystonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13
Cervical Dystonia Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
Proportion of Cervical Dystonia to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15
Cervical Dystonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Cervical Dystonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Cervical Dystonia to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 18
Cervical Dystonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Cervical Dystonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Cervical Dystonia Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Cervical Dystonia Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Cervical Dystonia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Cervical Dystonia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Cervical Dystonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Cervical Dystonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Cervical Dystonia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Cervical Dystonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Cervical Dystonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures

Cervical Dystonia Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Cervical Dystonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Cervical Dystonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Cervical Dystonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Cervical Dystonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Cervical Dystonia Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Cervical Dystonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13
Cervical Dystonia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14
Proportion of Cervical Dystonia to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15
Cervical Dystonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Cervical Dystonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Cervical Dystonia to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 18
Cervical Dystonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Cervical Dystonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Cervical Dystonia Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Cervical Dystonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Cervical Dystonia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Cervical Dystonia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Cervical Dystonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Cervical Dystonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Cervical Dystonia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Cervical Dystonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Cervical Dystonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
GlobalData Methodology 70

Filed in: Pharmaceutical
Publisher : GlobalData